US 6528661
Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
expired A61KA61K9/282A61K9/5021
Quick answer
US patent 6528661 (Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Mar 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K9/282, A61K9/5021